8-K
filed February 22, 2023, 6:59 PM ET
ticker IOSP
CIK 0001054905
earnings
confidence high
sentiment positive
materiality 0.70
Innospec Q4 revenue up 24% to $510.7M; adjusted EPS $1.20 vs $1.30 YoY; net cash $147.1M
INNOSPEC INC.
2022-FY EPS reported
$5.32
revenue$1,963,700,000
- Q4 revenue $510.7M (+24% YoY); net income $25.5M ($1.02 diluted EPS) vs $23.9M ($0.96) last year.
- Adjusted non-GAAP EPS $1.20, down from $1.30 YoY, impacted by $0.36 higher tax charges.
- EBITDA $54.3M vs $44.8M; operating income growth 31% for quarter, 42% for full year.
- Generated $78.4M cash from operations; net cash improved to $147.1M from $100.5M at Q3 end.
- Paid semi-annual dividend of $0.65/share; repurchased 8,514 shares for $0.7M.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.4
INNOSPEC INC. reported financial results for the fiscal year ended December 31, 2022.
- Period
- the fiscal year ended December 31, 2022
- Result
- reported results
Exact text from the filing
On February 21, 2023 Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal year and quarter ended December 31, 2022 (the “Press Release”).
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
INNOSPEC INC. reported the fourth quarter ended December 31, 2022 results: revenue $510.7 million, net income $25.5 million, EPS $1.02 per diluted share.
- Period
- the fourth quarter ended December 31, 2022
- Revenue
- $510.7 million
- Net income
- $25.5 million
- EPS
- $1.02 per diluted share
- Result
- reported results
Exact text from the filing
Total revenues for the fourth quarter were $510.7 million, an increase of 24 percent from $413.2 million in the corresponding period last year. Net income for the quarter was $25.5 million or $1.02 per diluted share compared to $23.9 million or 96 cents per diluted share recorded last year.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.